Description
Health Canada will also continue to identify and acquire COVID-19 treatments and therapies; expedite regulatory reviews of drugs, medical devices and disinfectants; procure any needed medical and personal protective equipment; prioritize the review of COVID-19 tests, including new, innovative options and technologies; and pursue strategies to expand testing capacity.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| 2021–22 Departmental Plan: Health Canada | HTML | Open resource | |
| 2021–22 Departmental Plan: Health Canada | HTML | Open resource |